Browse diseases

…46-022-02251-2Daubon T, Hemadou A, Romero Garmendia I, Saleh M. Glioblastoma immune landscape and the potential of new immunotherapies. Fron…

…Background Glioblastoma (GBM) is an aggressive brain tumor with a poor prognosis. Only …

…hbehani GK, Riddell S, Cripe T, Cairo MS. Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vit…

…ferences in protein abundance. Interestingly, the male-dominant lung cancer subtype, LUSC, exhibited minimal sex-related differences in the…

…conductive to immune evasion, which is a hallmark of aggressive GBM…

…le-cell RNA sequencing and immunohistochemistry. C57BL/6 murine GBM models (CT-2A, SB28) were used to define mechanisms associated …

…Background Glioblastoma (GBM) poses significant challenges for CAR-T therapy due to ant…

…and results In vitro, IBDV infects and replicates within murine GBM cells and patient-derived GBM stem cells, inducing direct oncol…

…on, and cell proliferation using TNC-expressing patient-derived GBM cell lines cultured as adherent cells or as neurospheres. React…

… that bridges CD3 epsilon on murine T cells to IL13RA2-positive GBM cells was developed, and the therapeutic mechanism was investig…

…Background Glioblastoma (GBM) is the most common and lethal primary malignant brain tum…

…. In immunocompetent mouse models bearing orthotopic, syngeneic GBM transduced with mPIIB or an empty virus, animals were randomize…